SavedAdd your journal

Journals / Süleyman Demirel Üniversitesi Sağlık Bilimleri Dergisi / 2015 / Cilt: 6 - Sayı: 1

Biphosphonate related osteonecrosis of the jaws: Atypical clinical appearance

Bifosfonata bağlı çene kemiklerinde gelişen osteonekroz: Atipik klinik görüntü

Müge ÇINA AKSOY
Özge ŞAHİN KOLKESEN
Gülperi KOÇER
Timuçin BAYKUL
Pages
34–38
DOI
—
🏛️Bibliographic metadata and full text access for this article are provided via DergiPark.
DergiPark Record ↗
✨

AI Summary & Key Takeaways

AI Insight
⚡ TL;DR(Too Long; Didn't Read)

The Stage 2 patients should be followed up long-term after conservative treatment, as well as the primary diagnosis of bisphosphonate related osteonecrosis of the jaws without exposed necrotic bone, after surgical debridement, mucosal healing can completed and the bone necrosis may continue under the intact mucosa.

📌 3 Key Takeaways

🎯
Objective & Hypothesis:The clinical signs of Bisphosphonate related osteonecrosis of the jaws are exposed necrotic bone, pain, inflammation and pus drainage.
📊
Key Findings & Data:The absence of exposed necrotic bone, a characteristic clinical sign, can lead to late diagnosis and refractory treatment. 56-year-old female patient, admitted to our clinic with a complaint of pain in the right lower jaw.
💡
Conclusion & Impact:The Stage 2 patients should be followed up long-term after conservative treatment, as well as the primary diagnosis of bisphosphonate related osteonecrosis of the jaws without exposed necrotic bone, after surgical debridement, mucosal healing can completed and the bone necrosis may continue under the intact mucosa.
🔬Design:Research Article
📍Scope:Comprehensive Sample
⚙️Variables:Domain Parameters

Abstract

The clinical signs of Bisphosphonate related osteonecrosis of the jaws are exposed necrotic bone, pain, inflammation and pus drainage. The absence of exposed necrotic bone, a characteristic clinical sign, can lead to late diagnosis and refractory treatment. 56-year-old female patient, admitted to our clinic with a complaint of pain in the right lower jaw. Clinical and radiographic examination showed Stage 2 bisphosphonate related osteonecrosis and surgical debridement was performed; after surgery the mucosa healed completely, but it was determined that bone necrosis continued under the intact mucosa. A second surgery with sekestrectomy and curretage was performed. The Stage 2 patients should be followed up long-term after conservative treatment, as well as the primary diagnosis of bisphosphonate related osteonecrosis of the jaws without exposed necrotic bone, after surgical debridement, mucosal healing can completed and the bone necrosis may continue under the intact mucosa.

Özet

Bifosfonata bağlı çenelerde görülen osteonekrozun klinik bulguları, ekspoze nekrotik kemik yüzeyi, ağrı, enflamasyon, pürülan akıntı olarak sayılabilmektedir. Karakteristik klinik görüntü olan ekspoze nekrotik kemiğin olmaması, teşhisin güçleşmesi, tedavinin başarısızlığı ve uzamasına neden olabilmektedir. 56 yaşındaki kadın hasta, kliniğimize, sağ alt çenede ağrı şikayetiyle başvurdu. Yapılan klinik ve radyografik muayenesi sonucu bifosfonata bağlı Evre 2 osteonekroz teşhisiyle cerrahi debridman yapıldı. Kontroller sırasında mukozanın tam olarak iyileştiği, ancak kemik nekrozunun sağlam mukoza altında devam ettiği tespit edildi. Sekestrektomi ve küretaj ile ikinci cerrahi işlem yapıldı. Evre iki hastalarda konservatif tedavi sonrası hastanın uzun süreli takibi yapılmalı, primer teşhiste ekspoze nekrotik kemik varlığı olmaksızın gelişen osteonekrozlarda olduğu gibi, cerrahi debridman sonrası mukozada iyileşme gözlense de sağlam mukoza altında kemik nekrozunun devam edebileceği akılda tutulmalıdır.

🔖

Cite This Article

AKSOY, M. Ç., KOLKESEN, Ö. Ş., KOÇER, G., BAYKUL, T. (2015). Biphosphonate related osteonecrosis of the jaws: Atypical clinical appearance. Süleyman Demirel Üniversitesi Sağlık Bilimleri Dergisi, Cilt: 6 - Sayı: 1, 34–38. https://ajindex.com/articles/360432

📄 Full Text PDF Viewer

📄

PDF görüntüleyici hazırlanıyor...

References (10)

  1. Ruggiero SL, Drew SJ. Osteonecrosis of the jaws and bisphosphonate therapy. J Dent Res 2007;86(11):1013-1021. 2. Marx RE. Pamidronate (Aredia) and Zoledronate (Zometa) Induced Avascular Necrosis of The Jaws: A Growing Epidemic. J Oral Maxillofac Surg 2003;61:1115-1118.
  2. Woo SB, Hellstein JW, Kamlar JR. Narrative [corrective] review: bisphosphonates and osteonecrosis of the jaws. Ann Intern Med 2006;144:753-761.
  3. Hortobagyi GN, Theriault RL, Porter L, Blayney D, Lipton A, Sinoff C, Wheeler H, Simeone JF, Seaman J, Knight RD. Efficacy of pamidronate in reducing skeletal complications in patients with breast cancer and lytic bone metastases. N Engl J Med 1996;335(24):1785-1791.
  4. Gutta R, Louis PJ. Bisphosphonates and osteonecrosis of the jaws: science and rationale. Oral Surg Oral Med Oral Pathol Oral Radiol Endod 2007;104(2):186-193. Advisory Task Force on Bisphosphonate Related Osteonecrosis of the Jaws American Association of Oral Maxillofacial Surgeons. American Association of Oral Maxillofacial Surgeons position paper on bisphosphonate related osteonecrosis of the jaws. J Oral Maxillofac Surg 2007;65:396-377. Ruggiero SL. Bisphosphonate-related osteonecrosis of the jaw: an overview. Ann N Y Acad Sci 2011;1218:38-46.
  5. Fedele S, Porter SR, D'Aiuto F, Aljohani S, Vescovi P, Manfredi M, Arduino PG, Broccoletti R, Musciotto A, Di Fede O, Lazarovici TS, Campisi G, Yarom N. Nonexposed variant of bisphosphonate-associated osteonecrosis of the jaw: a case series. Am J Med 2010;123(11):1060-1064.
  6. Junquera L, Gallego L. Nonexposed bisphosphonate- related osteonecrosis of the jaws: another clinical variant? J Oral Maxillofac Surg 2008;66(7):1516-1517.
  7. Mawardi H, Treister N, Richardson P, Anderson K, Munshi N, Faiella RA, Woo SB. Sinus tracts--an early sign of bisphosphonate-associated osteonecrosis of the jaws? J Oral Maxillofac Surg 2009;67(3):593-601.
  8. Hutchinson M, O'Ryan F, Chavez V, Lathon PV, Sanchez G, Hatcher DC, Indresano AT, Lo JC. Radiographic findings in bisphosphonate-treated patients with stage 0 disease in the absence of bone exposure. J Oral Maxillofac Surg 2010;68(9):2232-2240.
  9. Patel S, Choyee S, Uyanne J, Nguyen A, Lee P, Sedghizadeh P, Kumar S, Lytle J, Shi S, Le A. Non-exposed bisphosphonate-related osteonecrosis of the jaw: a critical assessment of current definition, staging, and treatment guidelines. Oral Diseases 2012;18:625-632.
  10. Jabbour Z, El-Hakim M, Mesbah-Ardakani P, Henderson JE, Albuquerque R Jr. The outcomes of conservative and surgical tre